Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The inaugural NDORMS Imaging Competition saw a fantastic collection of submissions of microscopic things which have a great impact in our bodies. The winners were announced at an Imaging Symposium held at the Kennedy Institute.

The competition was launched by the Institute’s Microscopy and Imaging Facility to showcase exciting imaging studies taking place across the Department. 

The Symposium included talks from Oxford researchers Prof Robin Choudhury, Dr Bart Cornelissen, Prof Shankar Srinivas and Dr Kseniya Korobchevskeya, as well as from Prof Miep Helfrich from the University of Aberdeen. The speakers discussed how state-of-the-art imaging techniques are being applied to visualise the behaviour of molecules and cells in tissues to better understand cardiovascular inflammation, tumour growth, embryogenesis and bone repair. 

In his opening remarks, Professor Michael Dustin described how Oxford’s tremendous capabilities in imaging creates unique opportunities for collaboration across scientific fields. Speaking of the Symposium he said: “This is a great opportunity to highlight outstanding imaging being done in NDORMS and to build bridges to other centres of excellence with unique capabilities in Oxford and the UK.  For example, Prof Helfrich introduced the power of 3D block face scanning electron microscopy, which is accessible to NDORMS researchers through an instrument at nearby Oxford Brookes University.”

The winning images were selected by Oxford imaging experts Andrew Jefferson, Graham Brown, Ian Dobbie and Carina Monico and announced as:

Light Microscopy (Histology)

  • Marcia Curtinha, Masson’s Trichrome Staining of Femur (joint 1st Prize)
  • Jessica Malzahn, Hope in Endometriosis (joint 1st Prize)

Advanced Epiflourescence/Confocal/MP Microscopy

  • James Felce, Basophil Swarm (1st Prize)
  • Sam Olechnowicz, Myeloma Infiltration (2st Prize)

Super-Resolution Microscopy

  • Stefan Balint, Actin Mesh in Primary T cells (joint 1st Prize)
  • Kseniya Korobchevskaya, Cell Cultured on Gelatin-Coated Glass (joint 1st Prize)

Whole Body Imaging

  • Ana Espirito Santo, Fracture Healing in Real Time (1nd Prize)
  • Houfu Leng, Osmium Stain Locates Bone Marrow Adipocytes (2nd Prize)

Electron Microscopy

  • Edward Stace, Connections (1st Prize)
  • Navraj Nagra, SEM of decellularised human debris (2nd Prize)

The winners received a £150 or £100 cash prize and a certificate presented by NDORMS investigators including Prof Andrew Carr and Prof Fiona Powrie.

The Symposium organisers Prof Michael Dustin, Dr Anjali Kusumbe and Dr Volodymyr Nechypouk-Zloy would like to thank Zeiss, Perkin Elmer, Olympus, CoolLED, K-Tec and Atlantic Imaging Limited for their kind sponsorship of the event.

 

Similar stories

Two prestigious Hunterian Professorships awarded to NDORMS researchers

Conrad Harrison and Tom Layton have both been awarded Hunterian Professorships for 2022 by the Royal College of Surgeons of England

Dr Alex Clarke wins Emerging Leaders Prize for lupus research

Alex is one of three exceptional lupus researchers that have been announced as winners of the Medical Research Foundation’s sixth Emerging Leaders Prize.

The Kennedy’s research strongly endorsed following independent review

We recently welcomed our Scientific Advisory Board (SAB) and the Kennedy Trust Scientific Review Board (TSRB) to the Institute to review our current activities and future plans.

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Mathematician boosts data science research at the Kennedy Institute

Welcome to Yang Luo who has joined the Kennedy Institute as the Principal Investigator of the Luo Group. Her lab is leading the investigation into how genetic variations contribute to diseases of the immune system.

NIHR funding for musculoskeletal and inflammatory disease research

Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients.